Racura Oncology, an Australian Phase 3 stage clinical biopharmaceutical company, reports the discovery of the primary mechanism of action (MOA) of its lead oncology asset, (E,E)-bisantrene. Bisantrene ...

The launch brings software providers Health Metrics, MOA Benchmarking and CareLineLive together in a unified technology ...

The new exhibit invites visitors to become active participants in kinetic digital art.

The proposed Wellington City Council relief fund for businesses was left $200,000 below what was planned after Wellington ...

Perspective is advancing radiopharmaceutical therapies, with a pivotal data readouts expected in 2026 in NETs, plus melanoma ...

NKTR looks de-risked after positive Rezpeg phase 2 data in atopic dermatitis & alopecia areata, with 80% upside and $1.1B ...

Despite a low final score in the Michigan Football Spring Game, 3 of the most hyped freshmen showed enough to make fans feel ...

After 225 years extinct, scientists have sequenced DNA and edited cells to move the bluebuck closer to a return.

South Dakota counties and cities that received the first $9.6 million of national opioid settlement money have spent less ...

Sarawak is exploring strategic partnerships in the United Kingdom to advance semiconductor design and satellite technology as ...